10/01/2012 – The Granuflo Lawsuit has officially begun. What may have been the first Granuflo Lawsuit to have been filed was served on the Frienus USA INC, naming the manufacturer of Granuflo and several of its subsidiary companies as defendants in a Granuflo Lawsuit in which a the family of an Alabama man brought suit as a result of the death of their family member.
Granuflo Lawsuit Lawyer
Anyone who has been injured by Granuflo and contact (800) 611-7080 to arrange a free consultation with an attorney accepting clients for the Granflo Lawsuit. You may also arrange a free legal consultation by using the contact form on this page.
The Alabama Granuflo Lawsuit essentially alleges that the death of the plaintiffs family member was a direct result of the the administration of Granuflo. Granuflo is an Acid Concentrate used as an additive in dialysis treatments for patients who have severe kidney problems or total kidney failure.
The Granuflo Lawsuit further alleges that the makers of Granuflo knew as early as November of 2011 that there was a significant increased risk of heart attacks which could lead to death associated with the use of Granuflo. It does not appear however that Fresenius shared this information with the United States Food and Drug administration or patients being administered Granuflo at the time they discovered the problem.
Cases in which significant relevant information can be proven to have been withheld by the manufacturer of a pharmaceutical product can often create a more dire situation for the drug manufacturer than would existed had they revealed the information to the public as soon as they became aware that their product might have side effects which were previously unknown.
Granuflo Heart Attacks
A person undergoing hemodialysis already has a significant medical condition which can compromise their overall health and make it more difficult for them to withstand or recover from other medical problems they may experience. Although we are unaware of any studies that have been conducted that focused on the death rate among dialysis patient’s verses otherwise healthy individuals it is logical to assume that anyone with significantly compromised health may be more likely to die as a result of a heart attack than someone who was otherwise healthy.
At some point after the United States Food and Drug Administration became aware of the link between Granuflo and heart attacks. A Grauflo FDA recall was issued in March of 2012. Of course this Granuflo FDA action will have occured too late for those who were administered Granuflo and suffered a heart attack. The bulk of the Granuflo Lawsuit plaintiffs will be those who suffered a granuflo heart attack prior to the FDA recall.
The Granuflo Recall by the FDA was a Class 1 Recall. A class one recall is one of the most significant recalls that the FDA issues. In March of 2012 the FDA cautioned clinicians to be aware of the concentration of acetate of sodium diacetate contained in Granuflo..The caution included warnings that these substances increase the risk of law blood pressure, hypoexemia, hyercapnia and cardiac arythmia. The FDA caution when on to warn that these risks can lead to cardiopulmonary arrest. Cardio Pulmonary arrest is more commonly called “heart attack”. Visit this link for more information on the Granuflo Lawsuit FDA Recall.